GALE Galenica AG

Galenica increases shareholding in Redcare Pharmacy to 10%

Galenica AG / Key word(s): Investment
Galenica increases shareholding in Redcare Pharmacy to 10%

22.07.2024 / 18:11 CET/CEST


Press release

Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V.

As part of the strategic partnership between Galenica and Redcare Pharmacy through the establishment of the joint venture Mediservice, Galenica has held a 7.9% stake in Redcare Pharmacy since May 2023. By increasing its participation, Galenica is strengthening its cooperation with Redcare Pharmacy, which has developed positively since the partnership was established. Galenica believes in the successful further development of Europe’s leading online pharmacy and intends to maintain its investment in Redcare Pharmacy in the long term. By increasing its stake to more than 10%, Galenica will be able to benefit from tax-free dividends and capital gains in the future. There are no plans to further increase the investment.

Dates for the diary

6 August 2024 Publication of Galenica Group half-year results 2024
24 October 2024 Galenica Group sales update
23 January 2025 Publication 2024 sales of the Galenica Group

 

For further information, please contact:

 

Media Relations:
E-Mail:
Tel. 7
Investor Relations:
E-Mail:
Tel. 1

Welcome to the Galenica network!
Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market. We offer fully integrated solutions both for customers and patients as well as for pharmacies, drugstores, medical practices, hospitals, retirement and nursing homes, home care providers, wholesalers, pharmaceutical companies, health insurance funds and other partners.
Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information concerning Galenica can be found at .



End of Media Release


Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: 11
E-mail:
Internet:
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 1951159

 
End of News EQS News Service

1951159  22.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1951159&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
22/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Galenica AG

Juan Ros-Padilla
  • Juan Ros-Padilla

Galenica : Quality comes at a price

Galenica is a well-managed and resilient company that has an unassailable dominance of the Swiss pharma distribution and related services. Over the years the company has earned a quality compounder reputation (+12% annualised TRS since IPO) which is reflected in its 20% average premium vs the SMI. Going forward we expect the company to keep a robust TRS profile of 8-9% p.a. (ex M&A). We initiate our coverage with a Neutral rating as its current premium (30%) and the limited upside to our target...

Galenica AG: 1 director

A director at Galenica AG sold 3,000 shares at 83.305CHF and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Galenica nomme Nadine Balkanyi-Nordmann au Conseil d’administration

Galenica AG / Mot-clé(s) : Personnel Galenica nomme Nadine Balkanyi-Nordmann au Conseil d’administration 23.01.2025 / 07:00 CET/CEST Communiqué de presse Nadine Balkanyi-Nordmann, experte expérimentée en droit, compliance et gouvernance, sera proposée à l’élection au Conseil d’administration lors de la prochaine Assemblée générale du Groupe Galenica. Lors de la prochaine Assemblée générale du 10 avril 2025, il sera proposé aux actionnaires d’élire un nouveau membre au Conseil d’administration de Galenica: Nadine Balkanyi-Nordmann (1972), personnalité dirigeante reconnue et experte...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch